Cases & Deals

Sanofi completes $2 billion bond issue in U.S. public offering

Clients Sanofi

Jones Day represented Sanofi, a global biopharmaceutical company, in its U.S. public offering of $2 billion of notes in two fixed rate tranches. Barclays Capital Inc. and Morgan Stanley & Co. LLC acted as global coordinators for the offering. Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Morgan Stanley & Co. LLC, and MUFG Securities Americas Inc. acted as joint bookrunners for the offering.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.